Professor Monty Mythen’s full presentation regarding ‘the FEDORA trial’.
This piece was originally presented during the Third Annual Quality Improvement Leadership Forum, 2018, at the Union League Club in Philidelphia.
The trial looked at the effect of goal-directed haemodynamic therapy on postoperative complications in low?moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial).
Randomised Controlled Multicentre trial; n=420; GDHT vs Control
“Oesophageal Doppler monitor-guided GDHT reduced postoperative complications and hospital length of stay in low?moderate risk patients undergoing intermediate risk surgery, with no difference in mortality at 180 days.”
Click here for full text.